Furthermore, MMP-13 levels were closely associated with HIF-1α expression (r = 0.679, P < 0.001), lymph node metastasis, clinical stage (all P < 0.05) and poor prognosis in NPC patients (P < 0.01). This evidence concerns the gene HIF1A and metastatic malignant neoplasm in the lymph nodes.